Probiotics in Pulmonaty Rehabilitation for COPD
Probiotics in the Management of Pulmonary Rehabilitation for COPD: A Randomized Controlled Trial
Fu Jen Catholic University
60 participants
Dec 5, 2024
INTERVENTIONAL
Conditions
Summary
This study aims to investigate various aspects of patients with chronic respiratory diseases undergoing pulmonary rehabilitation supplemented with probiotics. The focus will be on clinical physiological responses, functional performance, respiratory status assessments, nutritional status evaluations, body composition analyses, and biochemical blood parameters, with a primary emphasis on the anti-inflammatory response.
Eligibility
Inclusion Criteria3
- Willing to sign a written informed consent form.
- Diagnosed with pre-COPD or COPD stage I-IV according to the 2023 GOLD guidelines.
- Undergoing pulmonary rehabilitation therapy for more than three months.
Exclusion Criteria6
- Under 18 years old.
- Diagnosed with neuromuscular diseases.
- Experienced respiratory disease exacerbation requiring emergency care or hospitalization in the past three months.
- Unable to cooperate with cardiopulmonary exercise testing.
- Has other diseases or behavioral restrictions preventing participation in exercise training for over one year.
- Assessed by a physician to have severe malnutrition or a significantly low BMI.
Interventions
probiotic supplementation will be administered, while participants continue undergoing routine pulmonary rehabilitation therapy
undergo routine pulmonary rehabilitation without probiotics intervention
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06717659